跳转至内容
Merck
所有图片(1)

Key Documents

更多文件

53695

Sigma-Aldrich

3-(三苯甲硫基)丙酸

≥97.0% (T)

登录查看公司和协议定价
所有图片(1)

About This Item

线性分子式:
(C6H5)3CSCH2CH2COOH
CAS号:
27144-18-9
分子量:
348.46
MDL號碼:
MFCD00237291
分類程式碼代碼:
12352100
PubChem物質ID:
57651432
NACRES:
NA.22

品質等級

100

化驗

≥97.0% (T)

SMILES 字串

OC(=O)CCSC(c1ccccc1)(c2ccccc2)c3ccccc3

InChI

1S/C22H20O2S/c23-21(24)16-17-25-22(18-10-4-1-5-11-18,19-12-6-2-7-13-19)20-14-8-3-9-15-20/h1-15H,16-17H2,(H,23,24)

InChI 密鑰

AECGEIVNZGQBJT-UHFFFAOYSA-N

相关类别

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險分類

Acute Tox. 4 Oral - Aquatic Chronic 4 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Mathew R Schnorenberg et al.
ACS omega, 3(10), 14144-14150 (2018-11-10)
Despite the therapeutic promise of phospholipid-based nanocarriers, a major obstacle to their widespread clinical translation is a susceptibility to fatty acid ester hydrolysis, leading to lack of quality control and inconsistencies in self-assembly formulations. Using electrospray ionization mass spectrometry fragmentation
Naglaa Salem El-Sayed et al.
Molecules (Basel, Switzerland), 24(7) (2019-04-14)
Cell-penetrating peptide [WR]₅ has been previously shown to be an efficient molecular transporter for various hydrophilic and hydrophobic molecules. The peptide was synthesized using Fmoc/tBu solid-phase chemistry, and one arginine was replaced with one lysine to enable the conjugation with
Partha Laskar et al.
Nanoscale, 11(42), 20058-20071 (2019-10-16)
Combination therapy involving chemotherapeutic drugs and genes is emerging as a promising strategy to provide a synergistic therapeutic effect, to overcome drug resistance while reducing the severe side effects associated with conventional chemotherapeutic drugs. However, the lack of nanomedicines able
Scott H Medina et al.
Journal of controlled release : official journal of the Controlled Release Society, 209, 317-326 (2015-05-17)
Many lead molecules identified in drug discovery campaigns are eliminated from consideration due to poor solubility and low cell permeability. These orphaned molecules could have clinical value if solubilized and delivered properly. SVS-1 is a de novo designed peptide that

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门